Skip to main content

Protalix BioTherapeutics, Inc.

PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001006281

No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in Protalix BioTherapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
33
−5 vs. Q1 2021
Shares held
4.56M
−4.26M (−48.3%) vs. Q1 2021
Total value
$8.71M
−$30.6M (−77.9%) vs. Q1 2021
New holders
9
12 more added
Sold out
14
6 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 33 institutions
Q1 2021: 38 institutionsQ2 2021: 33 institutionsQ3 2021: 35 institutionsQ4 2021: 31 institutionsQ1 2022: 32 institutionsQ2 2022: 30 institutionsQ3 2022: 27 institutionsQ4 2022: 26 institutionsQ1 2023: 34 institutionsQ2 2023: 66 institutionsQ3 2023: 61 institutionsQ4 2023: 66 institutionsQ1 2024: 64 institutionsQ2 2024: 66 institutionsQ3 2024: 45 institutionsQ4 2024: 46 institutionsQ1 2025: 63 institutionsQ2 2025: 63 institutionsQ3 2025: 77 institutionsQ4 2025: 83 institutionsQ1 2026: 100 institutionsQ2 2026: 101 institutions
Value heldQ2 2021: $8.71M
Q1 2021: $39.4MQ2 2021: $8.71MQ3 2021: $5.91MQ4 2021: $2.52MQ1 2022: $1.29MQ2 2022: $1.30MQ3 2022: $3.70MQ4 2022: $4.87MQ1 2023: $6.15MQ2 2023: $17.9MQ3 2023: $15.2MQ4 2023: $18.1MQ1 2024: $12.4MQ2 2024: $6.60MQ3 2024: $3.53MQ4 2024: $8.40MQ1 2025: $21.0MQ2 2025: $17.6MQ3 2025: $31.0MQ4 2025: $26.8MQ1 2026: $36.6MQ2 2026: $33.7M
Institutions holding PLX and their total value by quarter
QuarterHoldersValue
Q2 2026101$33.7M
Q1 2026100$36.6M
Q4 202583$26.8M
Q3 202577$31.0M
Q2 202563$17.6M
Q1 202563$21.0M
Q4 202446$8.40M
Q3 202445$3.53M
Q2 202466$6.60M
Q1 202464$12.4M
Q4 202366$18.1M
Q3 202361$15.2M
Q2 202366$17.9M
Q1 202334$6.15M
Q4 202226$4.87M
Q3 202227$3.70M
Q2 202230$1.30M
Q1 202232$1.29M
Q4 202131$2.52M
Q3 202135$5.91M
Q2 202133$8.71M
Q1 202138$39.4M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q1 2021.

Institutions holding PLX in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Morgan Stanley1,861,819$3.56M0.00%+1,861,769+3,723,538.0%Added
Meitav Dash Investments Ltd488,664$934.0K0.01%+488,664New
Bridgeway Capital Management, LLC393,890$752.0K0.01%+91,299+30.2%Added
Walleye Capital LLC346,539$662.0K0.02%+346,539New
Susquehanna International Group, LLP283,145$541.0K0.00%+79,332+38.9%Added
Phoenix Holdings Ltd.244,113$466.0K0.01%00.0%Unchanged
Group One Trading, L.P.179,088$342.0K0.01%+179,088New
Walleye Trading LLC135,000$258.0K0.01%+135,000New
BlackRock Inc.122,499$234.0K0.00%+121,128+8,835.0%Added
Citadel Advisors LLC115,886$221.0K0.00%+100,114+634.8%Added
Simplex Trading, LLC69,049$131.0K0.00%+24,801+56.0%Added
Credit Suisse AG65,925$126.0K0.00%+55,925+559.3%Added
Susquehanna Fundamental Investments, LLC66,100$126.0K0.00%+66,100New
Wolverine Trading, LLC45,306$87.0K0.00%+26,508+141.0%Added
Jane Street Group, LLC31,665$60.0K0.00%−16,663−34.5%Reduced
Renaissance Technologies LLC30,075$57.0K0.00%−477,559−94.1%Reduced
XTX Topco Ltd17,148$33.0K0.01%+17,148New
Spire Wealth Management14,000$27.0K0.00%+12,000+600.0%Added
Davenport & Co LLC12,000$23.0K0.00%00.0%Unchanged
Cutler Group LP6,900$13.0K0.00%+6,900New
Psagot Investment House Ltd.6,000$11.0K0.00%−3,089,741−99.8%Reduced
Bank of America Corp5,873$11.0K0.00%−997−14.5%Reduced
Federated Hermes, Inc.5,761$11.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)4,658$9.00K0.00%+3,570+328.1%Added
UBS Group AG1,925$3.00K0.00%−270−12.3%Reduced
Red Door Wealth Management, LLC2,000$3.00K0.00%+2,000New
Federation des caisses Desjardins du Quebec1,100$2.10K0.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC1,000$2.00K0.00%−1,000−50.0%Reduced
Captrust Financial Advisors800$2.00K0.00%00.0%Unchanged
Gemmer Asset Management LLC800$2.00K0.00%00.0%Unchanged
Royal Bank of Canada1,120$2.00K0.00%+500+80.6%Added
Deutsche Bank AG873$2.00K0.00%+873New
Ten Capital Wealth Advisors, LLC325$1.00K0.00%+125+62.5%Added
Burrage Capital Management LLC0$00.00%−2,125,585−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−1,204,825−100.0%Sold out
UBS Oconnor LLC0$00.00%−445,171−100.0%Sold out
D.A. Davidson & Co.0$00.00%−130,700−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−122,184−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−89,278−100.0%Sold out
California Public Employees Retirement System0$00.00%−66,631−100.0%Sold out
Laurion Capital Management LP0$00.00%−42,813−100.0%Sold out
Virtu Financial LLC0$00.00%−27,744−100.0%Sold out
Capstone Investment Advisors, LLC0$00.00%−21,058−100.0%Sold out
Ground Swell Capital, LLC0$00.00%−14,684−100.0%Sold out
WealthShield Partners, LLC0$00.00%−3,000−100.0%Sold out
JPMorgan Chase & Co0$00.00%−1,293−100.0%Sold out
Aspire Private Capital, LLC0$00.00%−400−100.0%Sold out